Trouble reading this email? View it in your browser
European Federation of Pharmaceutical industries and associations

EFPIA Newsletter 3 December 2020


First COVID-19 vaccine approved

Nathalie Moll, EFPIA Director General

Commenting on the world’s first authorisation of a COVID-19 vaccine, Nathalie Moll said:

"Finding answers to health challenges is what drives us. It means never stopping asking questions, never giving up in the search for answers. And when a step forward happens, like yesterday's announcement of approval by the MHRA for the Pfizer BioNtech vaccine, it just drives us forward all the more. We know there is a long way to go, today is a good day and #WeWontRest in fighting this pandemic."

Read more




Working together towards better patient outcomes
03 December 2020

A new series of short films to showcase innovative partnerships that will change patient outcomes Read more

EFPIA statement on today's meeting of EU Health Ministers
02 December 2020

In line with many of the views shared by Member States at today’s video conference of Health Ministers, EFPIA welcomes... Read more

EFPIA reaction to SPC evaluation publication
30 November 2020

The evidence in the studies supporting the evaluation and the SWD confirm that the SPC Regulation works well. Read more




Podcast: Is the pharmaceutical industry making too much money?
03 December 2020

Welcome to 19 Conversations Read more

Embracing AI to improve patient care and advance innovation in pharma (Guest blog)
03 December 2020 - Troels Ravn Bærentzen

EFPIA Position Paper on Artificial Intelligence Read more

The 10 key factors delaying patient access across Europe (Guest blog)
02 December 2020 - Christel Jansen

Most patients in European countries have to wait much longer than needed to access new cancer medicines Read more

Moving towards the next normal (Guest blog)
01 December 2020 - Steffen Lang

How changes driven by COVID-19 may shape pharma manufacturing in the long term Read more

Cancer – Acting Together Now (Guest blog)
01 December 2020 - Ivana Cattaneo

EU Cancer Plan delayed but the need for action remains Read more

To reimagine lung cancer care we must listen to and learn from patients
30 November 2020 - Michael Zaiac

From drug development to clinical trials, it is so important that work to advance lung cancer care is firmly grounded... Read more

Unlocking the value of personalised cancer care
30 November 2020 - Brian Cuffel - Mark Lawler - Jaap Verweij

New LSE report tackles barriers to realising the full potential of personalised oncology Read more




How to turn around the increasing burden of cardiovascular disease in Europe?
08 December 2020 (Virtual event)

Virtual event jointly organised by the European Heart Network and EFPIA Read more

Investing in innovation in health: A new industrial strategy for the COVID-19 era
10 December 2020 (Virtual event)

We look forward to welcoming you online on 10 December. Read more


What we are reading


Health budgets, patients pay the cost of fragmented diabetes care: report
On 24 November 2020 (Euractiv)

According to the report, 60 million people suffer from diabetes in Europe, a figure expected to raise to 68 million... Read more

The Big Problems
On 01 December 2020 (Science Translational Medicine)

Derek Lowe's commentary on drug discovery and the pharma industry. Read more